1. Home
  2. DCI vs BIO Comparison

DCI vs BIO Comparison

Compare DCI & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Donaldson Company Inc.

DCI

Donaldson Company Inc.

SELL

Current Price

$87.76

Market Cap

10.3B

Sector

Industrials

ML Signal

SELL

Logo Bio-Rad Laboratories Inc.

BIO

Bio-Rad Laboratories Inc.

SELL

Current Price

$351.64

Market Cap

10.1B

Sector

Industrials

ML Signal

SELL

Company Overview

Basic Information
Metric
DCI
BIO
Founded
1915
1952
Country
United States
United States
Employees
N/A
N/A
Industry
Pollution Control Equipment
Biotechnology: Laboratory Analytical Instruments
Sector
Industrials
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
10.3B
10.1B
IPO Year
2005
1994

Fundamental Metrics

Financial Performance
Metric
DCI
BIO
Price
$87.76
$351.64
Analyst Decision
Hold
Hold
Analyst Count
8
3
Target Price
$100.40
★ $335.00
AVG Volume (30 Days)
★ 580.0K
229.8K
Earning Date
12-03-2026
11-04-2026
Dividend Yield
★ 1.46%
N/A
EPS Growth
26.23
★ 142.61
EPS
★ 3.85
N/A
Revenue
★ $2,844,900,000.00
$2,583,200,000.00
Revenue This Year
$7.86
N/A
Revenue Next Year
$4.88
$2.13
P/E Ratio
$22.77
★ N/A
Revenue Growth
★ 4.05
0.65
52 Week Low
$79.61
$236.73
52 Week High
$112.84
$396.23

Technical Indicators

Market Signals
Indicator
DCI
BIO
Relative Strength Index (RSI) 46.54 38.36
Support Level $85.82 $284.88
Resistance Level $87.80 $391.87
Average True Range (ATR) 1.51 12.91
MACD 0.15 -2.15
Stochastic Oscillator 34.74 1.96

Price Performance

Historical Comparison
DCI
BIO

About DCI Donaldson Company Inc.

Donaldson is a leading manufacturer of filtration systems and replacement parts, including air filtration systems, liquid filtration systems, and dust, fume, and mist collectors. The company serves a diverse range of end markets, including construction, mining, agriculture, truck, and industrial. Its business is organized into three segments: mobile solutions, industrial solutions, and life sciences. Donaldson generated approximately $3.9 billion in revenue in its fiscal year 2026.

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: